MergerLinks Header Logo
Cover Image Jason Doren
Jason DorenARCH VENTURE PARTNERS

Jason Doren

General Counsel at ARCH VENTURE PARTNERS

Investor

Deal Bio

Total Deals6
Valued Deals6
Total Value£2,965M
Avg. Deal Size£494M

Sort

United States
Biotechnology
PrivatePrivate EquityVenture CapitalAcquisitionMinority
ERASCA

target

ERASCA

Arch Venture Partners

bidder

Arch Venture Partners

£161m

22 dealmakers

United States
Medical Services
Private EquityPrivateAcquisitionMinorityVenture Capital
INSITRO

target

INSITRO

Alexandria Venture Investments

bidder

Alexandria Venture Investments

£116m

38 dealmakers

United States
Biotechnology
MajorityPrivateAcquisitionPrivate EquityDomestic
Sana Biotechnology

target

Sana Biotechnology

Arch Venture Partners

bidder

Arch Venture Partners

£560m

30 dealmakers

United States
Biotechnology
AcquisitionDomesticMinorityVenture CapitalPrivate EquityPrivate
Encoded Therapeutics

target

Encoded Therapeutics

Gv (google Ventures)

bidder

Gv (google Ventures)

£106m

28 dealmakers

United States
Biotechnology
PrivateDomesticAcquisitionMajorityPrivate Equity
OMNIOME

target

OMNIOME

Pacific Biosciences

bidder

Pacific Biosciences

£583m

78 dealmakers

United States
Biotechnology
MajorityPrivateAcquisitionPrivate EquityCross Border
Vividion Therapeutics

target

Vividion Therapeutics

Bayer

bidder

Bayer

£1,437m

47 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US